[Ref.: #1692] |
Culture collection no. |
DSM 4479, ATCC 29906, CIP 103181, NCTC 11938, WDCM 00023, CDC PR 14, JCM 1669, CCUG 26767, CECT 4168, KCTC 2566, LMG 3257, NBRC 105697, CCM 7188 |
[Ref.: #74553] |
SI-ID 14302
|
* |
|
Literature: |
Only first 10 entries are displayed. Click here to see all.Click here to see only first 10 entries. |
|
|
Title |
Authors |
Journal |
DOI |
Year |
|
Pathogenicity |
Analysis of inflammatory cytokine expression in the urinary tract of BALB/c mice infected with Proteus (P.) mirabilis and enteroaggregative Escherichia (E.) coli (EAEC) strains. |
Melendez-Avalos A, Sainz-Espunes T, Castrillon-Rivera LE, Mendoza-Perez F, Palma-Ramos A, Castaneda-Sanchez JI, Drago-Serrano EM |
Folia Microbiol (Praha) |
10.1007/s12223-019-00714-2 |
2019 |
* |
Pathogenicity |
The impact of ethanol extract of propolis on biofilm forming by Proteus Mirabilis strains isolated from chronic wounds infections. |
Kwiecinska-Pirog J, Skowron K, Sniegowska A, Przekwas J, Balcerek M, Zaluski D, Gospodarek-Komkowska E |
Nat Prod Res |
10.1080/14786419.2018.1470513 |
2018 |
* |
Phylogeny |
Proteus alimentorum sp. nov., isolated from pork and lobster in Ma'anshan city, China. |
Dai H, Wang Y, Fang Y, Huang Z, Kan B, Wang D |
Int J Syst Evol Microbiol |
10.1099/ijsem.0.002689 |
2018 |
* |
Enzymology |
qnrA6 genetic environment and quinolone resistance conferred on Proteus mirabilis. |
Jayol A, Janvier F, Guillard T, Chau F, Merens A, Robert J, Fantin B, Bercot B, Cambau E |
J Antimicrob Chemother |
10.1093/jac/dkv431 |
2016 |
* |
Metabolism |
Combination of phenylpyruvic acid (PPA) pathway engineering and molecular engineering of L-amino acid deaminase improves PPA production with an Escherichia coli whole-cell biocatalyst. |
Hou Y, Hossain GS, Li J, Shin HD, Du G, Liu L |
Appl Microbiol Biotechnol |
10.1007/s00253-015-7048-5 |
2015 |
* |
Metabolism |
Production of phenylpyruvic acid from L-phenylalanine using an L-amino acid deaminase from Proteus mirabilis: comparison of enzymatic and whole-cell biotransformation approaches. |
Hou Y, Hossain GS, Li J, Shin HD, Liu L, Du G |
Appl Microbiol Biotechnol |
10.1007/s00253-015-6757-0 |
2015 |
* |
Pathogenicity |
Convenient syntheses of cyanuric chloride-derived NHC ligands, their Ag(I) and Au(I) complexes and antimicrobial activity. |
Almalioti F, MacDougall J, Hughes S, Hasson MM, Jenkins RL, Ward BD, Tizzard GJ, Coles SJ, Williams DW, Bamford S, Fallis IA, Dervisi A |
Dalton Trans |
10.1039/c3dt51400e |
2013 |
* |
Enzymology |
Expression and characterization of a second L-amino acid deaminase isolated from Proteus mirabilis in Escherichia coli. |
Baek JO, Seo JW, Kwon O, Seong SI, Kim IH, Kim CH |
J Basic Microbiol |
10.1002/jobm.201000086 |
2011 |
* |
Genetics |
Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate. |
Harada S, Ishii Y, Saga T, Tateda K, Yamaguchi K |
Antimicrob Agents Chemother |
10.1128/AAC.00111-10 |
2010 |
* |
Metabolism |
Enhanced microbial biomass assay using mutant luciferase resistant to benzalkonium chloride. |
Hattori N, Sakakibara T, Kajiyama N, Igarashi T, Maeda M, Murakami S |
Anal Biochem |
10.1016/s0003-2697(03)00322-1 |
2003 |
* |
Enzymology |
Integration of a transposon Tn1-encoded inhibitor-resistant beta-lactamase gene, bla(TEM-67) from Proteus mirabilis, into the Escherichia coli chromosome. |
Naas T, Zerbib M, Girlich D, Nordmann P |
Antimicrob Agents Chemother |
10.1128/AAC.47.1.19-26.2003 |
2003 |
* |
Genetics |
DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis. |
Weigel LM, Anderson GJ, Tenover FC |
Antimicrob Agents Chemother |
10.1128/AAC.46.8.2582-2587.2002 |
2002 |
* |
Metabolism |
Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins. |
Neuwirth C, Siebor E, Duez JM, Pechinot A, Kazmierczak A |
J Antimicrob Chemother |
10.1093/jac/36.2.335 |
1995 |
* |
Proteome |
Phytochemical Analysis and Antioxidant, Antibacterial, and Antifungal Effects of Essential Oil of Black Caraway (Nigella sativa L.) Seeds against Drug-Resistant Clinically Pathogenic Microorganisms. |
Zouirech O, Alyousef AA, El Barnossi A, El Moussaoui A, Bourhia M, Salamatullah AM, Ouahmane L, Giesy JP, Aboul-Soud MAM, Lyoussi B, Derwich E |
Biomed Res Int |
10.1155/2022/5218950 |
2022 |
* |
|
Characterization of a Novel Diarrheagenic Strain of Proteus mirabilis Associated With Food Poisoning in China. |
Gong Z, Shi X, Bai F, He X, Zhang H, Li Y, Wan Y, Lin Y, Qiu Y, Chen Q, Hu Q, Cao H |
Front Microbiol |
10.3389/fmicb.2019.02810 |
2019 |
* |
|
GC-MS Profiling, In Vitro Antioxidant, Antimicrobial, and In Silico NADPH Oxidase Inhibition Studies of Essential Oil of Juniperus thurifera Bark. |
Lafraxo S, El Moussaoui A, A Bin Jardan Y, El Barnossi A, Chebaibi M, Baammi S, Ait Akka A, Chebbac K, Akhazzane M, Chelouati T, Nafidi HA, Farid K, Bourhia M, Bari A |
Evid Based Complement Alternat Med |
10.1155/2022/6305672 |
2022 |
* |
|
Total Polyphenols Content, Antioxidant and Antimicrobial Activities of Leaves of Solanum elaeagnifolium Cav. from Morocco. |
Bouslamti M, El Barnossi A, Kara M, Alotaibi BS, Al Kamaly O, Assouguem A, Lyoussi B, Benjelloun AS |
Molecules |
10.3390/molecules27134322 |
2022 |
* |
|
- References
-
#1692 |
Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ;
DSM 4479
|
-
-
-
#37129 |
; Curators of the CIP;
|
-
-
#67770 |
Japan Collection of Microorganism (JCM) ; Curators of the JCM;
|
-
#68368 |
Automatically annotated from API 20E .
|
-
#68382 |
Automatically annotated from API zym .
|
-
-
#74553 |
Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.:
StrainInfo: A central database for resolving microbial strain identifiers
.
(
DOI 10.60712/SI-ID14302.1 )
|
-
#120971 |
Collection of Institut Pasteur ; Curators of the CIP;
CIP 103181
|
- * These data were automatically processed and therefore are not curated
Change proposal
Successfully sent
|